Clinical research focusing on plaque psoriasis and psoriatic arthritis, evaluating novel therapeutic approaches for both biologic-naive and experienced patients. Studies aim to assess treatment efficacy in reducing disease symptoms and improving patient outcomes.

Moderate to Severe Plaque Psoriasis
Active Psoriatic Arthritis
Long-term Safety Studies

Multiple investigations are comparing new therapeutic agents against placebo and established treatments.

02 Chronic Skin Disorders

Comprehensive studies addressing hidradenitis suppurativa and atopic dermatitis. Research focuses on evaluating new treatments for these challenging conditions, with emphasis on both immediate efficacy and long-term management.

Hidradenitis Suppurativa Management
Atopic Dermatitis Treatments
Novel Therapeutic Approaches

Trials are examining both topical and systemic treatments for optimal disease control.

03 Dermatological Conditions

Innovative research addressing various skin conditions including chronic venous ulcers, actinic keratosis, and rosacea. Studies range from stem cell therapies for wound healing to novel topical treatments.

Wound Healing Therapies
Skin Lesion Treatments
Inflammatory Conditions

Research includes both traditional and cutting-edge therapeutic approaches.

Back to Germany All countries

Clinical trials in Langenau – page 39

649 trials in Langenau

Marginal zone lymphoma+3

Study of Obinutuzumab as First-Line Treatment for Adult Patients with Marginal Zone Lymphoma Who Are Not Eligible for Local Therapy

Obesity

Study of Tirzepatide for Reducing Obesity and Related Health Issues in Adolescents

Neovascular age-related macular degeneration

Study on the Effectiveness of OPT-302 and Ranibizumab for Patients with Wet Age-related Macular Degeneration

Breast cancer

Study of Camizestrant and CDK4/6 Inhibitor for Patients with Advanced Breast Cancer with ESR1 Mutation

Nodal marginal zone B-cell lymphoma+2

Study on Copanlisib and Rituximab for Patients with Marginal Zone Lymphoma Needing Treatment After Local Therapy Failure or Relapse

Non-small cell lung cancer

Study of Chemotherapy with Osimertinib in Non-Small Cell Lung Cancer Patients Who Have Progressed After Initial Osimertinib Treatment

Diffuse large B-cell lymphoma

Study of Copanlisib with Rituximab and CHOP for Untreated Diffuse Large B-Cell Lymphoma in Patients Aged 18-80

Squamous cell carcinoma of the oral cavity+3

Study of Pembrolizumab with Lenvatinib after Chemoradiation Treatment in Patients with Locally Advanced Head and Neck Cancer who are PD-L1 Positive

Relapsing-remitting multiple sclerosis

Study on the Safety and Efficacy of CLS12311 and Autologous Red Blood Cells for Patients with Relapsing Remitting Multiple Sclerosis

Cholangiocarcinoma+3

Study of Durvalumab, Tremelimumab, and Capecitabine for Patients with Biliary Tract Cancer in an Adjuvant Setting

Endocrine ophthalmopathy

Study of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease

Hypertriglyceridaemia

Study on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia

Filter the trials

Other cities in Germany

Clinical research in Langenau

Prefer not to search on your own, or looking for clinical trials for a rare disease?